Treatment Response Optimized Clinical Decision Support AI System via Digital Twin Simulation
arXiv AIArchived Jun 17, 2026✓ Full text saved
arXiv:2606.17405v1 Announce Type: new Abstract: Clinical decision support AI systems (CDSASs) must adapt to evolving patient conditions in real-time while adhering to strict safety constraints. We present an online adaptive framework that integrates Treatment Effect (TE) estimation to quantify clinical benefits, a patient Digital Twin (DT) to simulate treatment trajectories, and Reinforcement Learning (RL) for sequential decision-making. The AI system is initially trained on historical medical r
Full text archived locally
✦ AI Summary· Claude Sonnet
Computer Science > Artificial Intelligence
[Submitted on 16 Jun 2026]
Treatment Response Optimized Clinical Decision Support AI System via Digital Twin Simulation
Xinyu Qin, Anil K. Sood, Ruiheng Yu, Sara Corvigno, Elaine Stur, Lu Wang
Clinical decision support AI systems (CDSASs) must adapt to evolving patient conditions in real-time while adhering to strict safety constraints. We present an online adaptive framework that integrates Treatment Effect (TE) estimation to quantify clinical benefits, a patient Digital Twin (DT) to simulate treatment trajectories, and Reinforcement Learning (RL) for sequential decision-making. The AI system is initially trained on historical medical records and operates in a continuous learning loop. To ensure safety, a rule-based module monitors vital signs and blocks contraindicated treatments. Cases with strong internal model disagreement are flagged for clinician review, simulated in our experiments via a pre-trained outcome model. We validate our framework using both a synthetic clinical simulator and a real-world ovarian cancer dataset from The Cancer Genome Atlas (TCGA). In both simulated and clinical settings, our method demonstrated superior effectiveness and stability in recommending treatments compared to standard computational baselines. Furthermore, the AI system maintains low latency and requires expert consultation for only a minority of cases in our experimental validation, demonstrating its potential as a safe, clinician-supervised tool for personalized medicine that continuously improves through practical use.
Comments: Accepted for presentation at the IEEE Engineering in Medicine and Biology Conference (EMBC) 2026
Subjects: Artificial Intelligence (cs.AI)
Cite as: arXiv:2606.17405 [cs.AI]
(or arXiv:2606.17405v1 [cs.AI] for this version)
https://doi.org/10.48550/arXiv.2606.17405
Focus to learn more
Submission history
From: Xinyu Qin [view email]
[v1] Tue, 16 Jun 2026 01:39:55 UTC (1,674 KB)
Access Paper:
HTML (experimental)
view license
Current browse context:
cs.AI
< prev | next >
new | recent | 2026-06
Change to browse by:
cs
References & Citations
NASA ADS
Google Scholar
Semantic Scholar
Export BibTeX Citation
Bookmark
Bibliographic Tools
Bibliographic and Citation Tools
Bibliographic Explorer Toggle
Bibliographic Explorer (What is the Explorer?)
Connected Papers Toggle
Connected Papers (What is Connected Papers?)
Litmaps Toggle
Litmaps (What is Litmaps?)
scite.ai Toggle
scite Smart Citations (What are Smart Citations?)
Code, Data, Media
Demos
Related Papers
About arXivLabs
Which authors of this paper are endorsers? | Disable MathJax (What is MathJax?)